Between Q3 2014 to Q3 2015, four ASP drug prices rose by more than $1K
Digoxin, which took the biggest cut in Q3 ASP drug prices, wasn’t the only drug that saw big changes in the past year. Some of this year’s big Q3 gainers have seen even bigger price gains since July 2014.
To read the full article, sign in and subscribe to the DecisionHealth Newsletters.